Ardent Health, Inc. (ARDT) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

High Risk
Significant dilution risk
Last updated: May 06, 2026

Risk Assessment Details

Potential Dilution: 112.05% of current shares
Recent Dilution: 24.21% (2 years)
Historical Dilution Factor: moderate recent dilution
Outstanding Shares
140M
Potential Supply
160M
Additional shares possible
Splits
None
Past 2 years

Summary

ARDT currently has 142M outstanding shares. with significant dilution risk as 159M authorized shares could dilute existing holders by 112.0%. The company has diluted shareholders by 24.21% over the past 2 years through share issuances.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
May 06, 2026

10-Q filing | 141.8M shares outstanding

140M 160M
Mar 16, 2026

10-K filing | 141.5M shares outstanding

140M 160M
Nov 14, 2025

10-Q filing | 141.2M shares outstanding

140M 160M
Aug 21, 2025

S-3 filing: Ardent Health, Inc. is filing an S-3 to register the offer and sale of up to $500 million in common stock, preferred stock, or debt securities, in any combination, together or separately, in one or more offerings, as well as the offer and sale of up to 120,453,642 shares of common stock by selling stockholders.

120M 160M
Aug 06, 2025

10-Q filing | 141.5M shares outstanding

140M 0
May 07, 2025

10-Q filing | 140.7M shares outstanding

140M 0
Feb 27, 2025

10-K filing | 132.7M shares outstanding

130M 0
Nov 07, 2024

10-Q filing | 137.5M shares outstanding

140M 0
Aug 14, 2024

10-Q filing | 142.8M shares outstanding

140M 0
Jul 15, 2024

S-1/A filing: This is an S-1/A filing for an offering of common stock. The underwriters include J.P. Morgan, BofA Securities, Morgan Stanley, Citigroup, Leerink Partners, RBC Capital Markets, Truist Securities, Mizuho, Capital One Securities and Loop Capital Markets. The company has agreed to a 180-day lock-up period.

N/A 0
Jun 21, 2024

S-1 filing: S-1 filing for an offering of common stock underwritten by J.P. Morgan, BofA Securities, Morgan Stanley, Citigroup, Leerink Partners, RBC Capital Markets, Truist Securities, Mizuho, Capital One Securities, and Loop Capital Markets.

N/A 0
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime